Impact of hyperglycemia on the results of percutaneous coronary interventions in patients with acute ST-segment elevation myocardial infarction


Cite item

Full Text

Abstract

Aim. To investigate the impact of hyperglycemia on the results of percutaneous coronary interventions (PCIs) in patients with acute ST-segment elevation myocardial infarction (ASTEMI). Subjects and methods. A study group consisted of 511 patients with hyperglycemia (blood glucose level (BGL) ≥7.77 mmol/L) who underwent primary PCIs in the period from 2005 to 2015. A comparison group included 579 patients (BGL ≥7.77 mmol/L). Results. Assessment of the results of hospital interventions revealed that the mortality rates in patients with hyperglycemia proved to be higher than in those with normal BGL (6.5 and 2.6%, respectively; p=0.002). No differences were found in the rates of stent thrombosis (1 and 1.4%; p=0.541) and recurrent myocardial infarction (1.2 and 1.6%; p=0.591). Major adverse cardiac events, including death, recurrent infarction, and stent thrombosis, were more frequently determined in the hyperglycemic patients (7.6 and 4.3%; p=0.020). No-reflow phenomenon statistically significantly more frequently developed in the patients with hyperglycemia (6.8 and 3.3%; p=0.007). Binary logistic regression analysis showed that the presence of hyperglycemia served as an independent predictor of hospital mortality (odds ratio (OR) 2.6; 95% confidence interval (CI), 1.4 to 4.8; p=0.002). The application of a random probability sampling technique revealed that mortality remained statistically significantly higher in the hyperglycemic patients than in the normoglycemic individuals at admission (6.7 and 2.6%; р=0.011). Conclusion. PCIs in patients with ASTEMI and hyperglycemia are characterized by higher mortality rates and the risk of major adverse cardiac events. Admission hyperglycemia is an independent predictor of hospital mortality.

About the authors

I S Bessonov

Тюменский кардиологический научный центр; Томский национальный исследовательский медицинский центр Российской академии наук

V A Kuznetsov

Тюменский кардиологический научный центр; Томский национальный исследовательский медицинский центр Российской академии наук

Yu V Potolinskaya

Тюменский кардиологический научный центр; Томский национальный исследовательский медицинский центр Российской академии наук

I P Zyrianov

Тюменский кардиологический научный центр; Томский национальный исследовательский медицинский центр Российской академии наук

S S Sapozhnikov

Тюменский кардиологический научный центр; Томский национальный исследовательский медицинский центр Российской академии наук

References

  1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. The Lancet. 2003;361:13-20. https://doi.org/10.1016/s0140-6736(03)12113-7
  2. Кузнецов В.А., Ярославская Е.И., Пушкарев Г.С., Зырянов И.П., Бессонов И.С., Горбатенко Е.А., Нямцу А.М. Взаимосвязь чрескожных коронарных вмешательств при острых формах ишемической болезни сердца и показателей смертности населения Тюменской области. Российский кардиологический журнал. 2014;6(110):42-46. https://doi.org/10.15829/1560-4071-2014-6-42-46
  3. Planer D, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Xu K, et al. Impact of hyperglycemia in patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention: The HORIZONS-AMI trial. Int J Cardiol 2013;167(6):2572-2579. https://doi.org/10.1016/j.ijcard.2012.06.054
  4. Naber CK, Mehta RH, Jünger C, Zeymer U, Wienbergen H, Sabin GV, et al. Impact of admission blood glucose on outcomes of nondiabetic patients with acute ST-elevation myocardial infarction (from the German Acute Coronary Syndromes egistry). The American Journal of Cardiology. 2009;103(5):583-587. https://doi.org/10.1016/j.amjcard.2008.11.005
  5. Zhang J, Zhou Y, Cao S, Yang Q, Yang S, Nie B. Impact of stress hyperglycemia on in-hospital stent thrombosis and prognosis in nondiabetic patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention. Coronary Artery Disease. 2013;24(5):352-356 https://doi.org/10.1097/mca.0b013e328361a942
  6. Deckers JW, van Domburg RT, Akkerhuis M, Nauta ST. Relation of Admission Glucose Levels, Short- and Long-Term (20-Year) Mortality After Acute Myocardial Infarction. The American Journal of Cardiology. 2013;112(9):1306-1310. https://doi.org/10.1016/j.amjcard.2013.06.007
  7. Koracevic GP. Proposal of a New Approach to Study and Categorize Stress Hyperglycemia in Acute Myocardial Infarction. The Journal of emergency medicine. 2016;51(1):31-36 https://doi.org/10.1016/j.jemermed.2015.03.047
  8. De Mulder M, Cornel J, Ploeg T, Boersma E, Umans VA. Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy. American Heart Journal. 2010;160(3):412-419. https://doi.org/10.1016/j.ahj.2010.06.047
  9. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2008;117(12):1610-1619. https://doi.org/10.1161/circulationaha.107.188629
  10. Stegenga ME, Crabben SN, Levi M, de Vos AF, Tanck MW, Sauerwein HP, et al. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes. 2006;55(6):1807-1812. https://doi.org/10.2337/db05-1543
  11. Jensen CJ, Eberle HC, Nassenstein K, Schlosser T, Farazandeh M, Naber CK, et al. Impact of hyperglycemia at admission in patients with acute ST-segment elevation myocardial infarction as assessed by contrast-enhanced MRI. Clinical Research in Cardiology. 2011;100(8):649-659. https://doi.org/10.1007/s00392-011-0290-7
  12. Ishihara M. Acute hyperglycemia in patients with acute myocardial infarction. Circulation Journal. 2012;76(3):563-571. https://doi.org/10.1253/circj.cj-11-1376
  13. Бессонов И.С., Кузнецов В.А., Зырянов И.П. и соавт. Первичные чрескожные коронарные вмешательства у пациентов с сахарным диабетом. Терапевтический архив. 2016;88(8):35-39. https://doi.org/10.17116/terarkh201688835-39
  14. Gruppetta M, Calleja N, Fava S. Long-Term Survival After Acute Myocardial Infarction and Relation to Type 2 Diabetes and Other Risk Factors. Clinical cardiology. 2010;33:424-429. https://doi.org/10.1002/clc.20776
  15. Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, et al. Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal. 2012;33(20):2569-2619. https://doi.org/10.1016/j.rec.2012.10.010
  16. American Diabetes Association. Standards of Medical Care in Diabetes — 2010. Diabetes Care. 2010;33(Suppl.1):S11-S61. https://doi.org/10.2337/dc10-s011

Copyright (c) 2017 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies